Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation | Zendy

Klaus Murbræch | Zendy; Torgeir Wethal | Zendy; Knut B. Smeland | Zendy; Harald Holte | Zendy; Jon Håvard Loge | Zendy; Espen Holte | Zendy; Assami Rösner | Zendy; Håvard Dalen | Zendy; Cecilie E. Kiserud | Zendy; Svend Aakhus | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation

Author(s) -

Klaus Murbræch,

Torgeir Wethal,

Knut B. Smeland,

Harald Holte,

Jon Håvard Loge,

Espen Holte,

Assami Rösner,

Håvard Dalen,

Cecilie E. Kiserud,

Svend Aakhus

Publication year - 2016

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2015.06.028

Subject(s) - medicine , cardiology , anthracycline , confidence interval , odds ratio , stenosis , transplantation , autologous stem cell transplantation , heart transplantation , lymphoma , hematopoietic stem cell transplantation , surgery , cancer , breast cancer

This study assessed the prevalence and associated risk factors for valvular dysfunction (VD) observed in adult lymphoma survivors (LS) after autologous hematopoietic stem cell transplantation (auto-HCT), and to determine whether anthracycline-containing chemotherapy (ACCT) alone in these patients is associated with VD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research